scholarly journals Identification and Management of Posterior Reversible Encephalopathy Syndrome in a Patient Enrolled in an Immunotherapy Combination Phase I Clinical Trial: A Case Study

2021 ◽  
Vol 8 (1) ◽  
pp. 103
Author(s):  
FedrickerD Barber
2016 ◽  
Vol 36 (5) ◽  
pp. 754-771 ◽  
Author(s):  
Alexina J. Mason ◽  
Juan Gonzalez-Maffe ◽  
Killian Quinn ◽  
Nicki Doyle ◽  
Ken Legg ◽  
...  

Author(s):  
Rakhi Gaur ◽  
Kalpana Thakur ◽  
Shiv Kumar Mudgal

PRES (posterior reversible encephalopathy syndrome) is a syndrome characterized by headache, confusion, seizures and altered mental status. A 26 years old woman came to emergency department with a history of hypertension, blurred vision and seizures. She was diagnosed as a G3P2L1 at 29 weeks + 1 day with IUGR with preeclampsia associated with deranged kidney functions later complicated by development of PRES. Patient underwent emergency LSCS and was kept on mechanical ventilator as condition worsened during immediate post-operative period. Dialysis was also done to regulate urea and creatinine levels. Patient was treated with anti-hypertensive, anti-epileptics, antibiotics, intravenous fluids and continuous monitoring of blood pressure. Patient’s condition improved gradually, and her discharge was planned. PRES is a condition, if managed in initial phase can lead to early recovery and reduce mortality. 


2011 ◽  
Vol 3 (9) ◽  
pp. 424-425
Author(s):  
Dr. Safiya I Shaikh ◽  
◽  
Dr. C Govindaraju Dr. C Govindaraju

Sign in / Sign up

Export Citation Format

Share Document